Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Rating) have been assigned an average rating of "Hold" from the twelve brokerages that are covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $48.11.
Several research firms have weighed in on XRAY. William Blair lowered DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Tuesday, April 19th. HC Wainwright lowered their price objective on DENTSPLY SIRONA from $58.00 to $48.00 and set a "hold" rating for the company in a research note on Friday, April 22nd. Morgan Stanley cut their target price on DENTSPLY SIRONA from $48.00 to $44.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 20th. Robert W. Baird downgraded DENTSPLY SIRONA from an "outperform" rating to a "neutral" rating and lowered their price target for the company from $67.00 to $48.00 in a report on Tuesday, April 19th. Finally, Piper Sandler decreased their price target on DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th.DENTSPLY SIRONA Price Performance
DENTSPLY SIRONA stock opened at $35.96 on Monday. DENTSPLY SIRONA has a 1 year low of $33.78 and a 1 year high of $66.98. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. The company's fifty day moving average price is $37.02 and its 200 day moving average price is $45.12. The stock has a market capitalization of $7.75 billion, a P/E ratio of 21.28 and a beta of 0.94.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Rating) last issued its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. The firm had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. DENTSPLY SIRONA's revenue was up 841.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.72 EPS. As a group, equities research analysts anticipate that DENTSPLY SIRONA will post 2.41 earnings per share for the current fiscal year. DENTSPLY SIRONA Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 8th. Investors of record on Friday, June 24th were paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 1.39%. The ex-dividend date of this dividend was Thursday, June 23rd. DENTSPLY SIRONA's payout ratio is currently 29.59%. Insider Activity
In related news, Director Eric Brandt sold 6,900 shares of the company's stock in a transaction on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total transaction of $273,999.00. Following the completion of the transaction, the director now owns 35,155 shares in the company, valued at $1,396,005.05. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.76% of the stock is owned by corporate insiders. Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in XRAY. BlackRock Inc. boosted its stake in DENTSPLY SIRONA by 36.1% in the 1st quarter. BlackRock Inc. now owns 24,083,158 shares of the medical instruments supplier's stock worth $1,185,372,000 after purchasing an additional 6,382,605 shares in the last quarter. Wellington Management Group LLP increased its holdings in DENTSPLY SIRONA by 83.1% in the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier's stock worth $270,829,000 after acquiring an additional 2,497,773 shares in the last quarter. Ceredex Value Advisors LLC increased its holdings in DENTSPLY SIRONA by 147.6% in the 4th quarter. Ceredex Value Advisors LLC now owns 3,231,363 shares of the medical instruments supplier's stock worth $180,631,000 after acquiring an additional 1,926,113 shares in the last quarter. American Century Companies Inc. boosted its stake in DENTSPLY SIRONA by 8,220.9% during the 1st quarter. American Century Companies Inc. now owns 1,292,987 shares of the medical instruments supplier's stock worth $63,641,000 after purchasing an additional 1,277,448 shares during the last quarter. Finally, First Eagle Investment Management LLC boosted its stake in DENTSPLY SIRONA by 17.8% during the 1st quarter. First Eagle Investment Management LLC now owns 8,460,416 shares of the medical instruments supplier's stock worth $416,422,000 after purchasing an additional 1,276,404 shares during the last quarter. Hedge funds and other institutional investors own 94.79% of the company's stock. DENTSPLY SIRONA Company Profile (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.Recommended StoriesGet a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)How to Find and Determine Which Stocks Are Worth Holding Through a Bear Market Trip Advisor Stock Might Be Ready for a RideSnowflake Stock May Have Stopped FallingThree Watchlist Stocks to Capitalize on Sector RotationMarketBeat: Week in Review 7/18 – 7/22
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Today Kate chats with Clark Kendall, CEO of Kendall Capital. Clark offers some practical steps to allocate your money, as well as invest for tax advantages.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.